Scientists engineer CRISPR technologies that use Cas proteins and guide RNAs to target genes for in vitro and in vivo genome editing. Cas9-mediated tools are the foundation of CRISPR technologies, setting the stage for new generation base editors and prime editors, and opening the door to genome editing therapeutics with greater precision.
Download this poster from The Scientist to learn about the advent of base editing and prime editing approaches and applications.